All news from Anaesthesiology

Non-Communicable Diseases ‘Behind Most Deaths In India’

Almost 61% of all deaths in India have been attributed to non-communicable diseases, by a 2017 report of the World Health Organisation (WHO). About 23% of the population is at risk of premature death due to such diseases, says the UN agency, which releases its “progress monitor” on non-communicable diseases annually.

The document sheds some light on the changing trends of ‘burden of diseases’ in various countries, and points out to an increasing occurrence of non-communicable diseases (NCDs) in developing countries such as India – a discernable trend that is visible since past two decades.

Cell Aging Could Prevent Diabetes

According to a new study, reserchers have discovered the effects of aging in our cells could allow doctors to cure or prevent diabetes, fatty liver disease, and other metabolic diseases and possibly even turn back the clock on aging itself. The new finding suggests that fatty liver disease and other unwanted effects of aging may be the result of our cells' nuclei, the compartment containing our DNA getting wrinkly. Those wrinkles appear to prevent our genes from functioning properly.

Patient Preferences For Diagnostic Testing In The Emergency Department

Researchers hypothesized that a patient's willingness to undergo diagnostic testing is influenced by the potential benefit, risk, and personal cost. Patient preferences for diagnostic testing differed significantly across levels of risk, benefit, and cost of diagnostic testing, but cost was the strongest and most consistent factor associated with decreased desire for testing. The study was published in Academic Emergency Medicine (AEM), a journal of the Society for Academic Emergency Medicine (SAEM).

Baby Birth; First In Utero Stem Cell Transplant Trial

UC San Francisco researchers have safely transplanted a woman's stem cells into her growing fetus, leading to the live birth of an infant with a normally fatal fetal condition. The infant, who had been critically ill during the second-trimester of pregnancy due to alpha thalassemia, is the first patient enrolled in the world's first clinical trial using blood stem cells transplanted prior to birth